Ribociclib in the treatment of HR+ HER2-negative metastatic breast cancer: updated results from the randomized clinical trials and their role in the clinical practice

Por I. V. Kolyadina
Publicado em 2021-09-01

10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice

Por I. V. Kolyadina
Publicado em 2021-10-01

Key studies that have changed the history and treatment of early HER2+ breast cancer: focus on individual therapy

Por I. V. Kolyadina, I. V. Poddubnaya
Publicado em 2021-01-01

The role of Taxotere in adjuvant therapy for early breast cancer

Por I. V. Kolyadina, I. V. Poddubnaya
Publicado em 2014-07-01

Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy

Por I V Kolyadina, I V Poddubnaya
Publicado em 2010-03-01

Possibilities of mammography, ultrasound, and MRI in the differential diagnosis of microcarcinomas of various biological subtypes of invasive breast cancer

Por G. S. Alieva, G. P. Korzhenkova, I. V. Kolyadina
Publicado em 2021-03-01

Possibilities of surgical treatment for locally recurrent and complicated breast cancer

Por V. P. Letyagin, I. V. Kolyadina, I. V. Vysotskaya
Publicado em 2015-09-01

Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy

Por I V Kolyadina, N P Makarenko, I V Poddubnaya
Publicado em 2012-12-01

Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy

Por I V Kolyadina, N P Makarenko, I V Poddubnaya
Publicado em 2010-03-01

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?

Por O. O. Gordeeva, L. G. Zhukova, I. V. Kolyadina, I. P. Ganshina
Publicado em 2019-04-01

Radio-induced breast angiosarcoma: features of diagnostics and treatment (a clinical case and literature review)

Por I. V. Kolyadina, V. V. Kometova, Yu. V. Bikeev, S. V. Khokhlova, V. V. Rodionov
Publicado em 2020-11-01

Therapeutic pathomorphism of malignancies: Clinical and morphological criteria. Classifications. Prognostic value of therapeutic pathomorphism in breast cancer and other tumors

Por A. A. Lisayeva, Ya. V. Vishnevskaya, E. M. Roshchin, D. V. Komov, I. V. Kolyadina
Publicado em 2014-08-01

Olaparib in the metastatic HER2-negative breast cancer setting

Por L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova
Publicado em 2020-12-01

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer

Por I. P. Ganshina, D. A. Filonenko, O. O. Gordeeva, E. V. Lubennikova, I. V. Kolyadina, A. A. Mescheryakov
Publicado em 2019-06-01

Preliminary results of accelerated partial breast irradiation in the combination organ-saving treatment of patients with early-stage breast cancer

Por O. P. Trofimova, I. V. Kolyadina, S. F. Avramidi, Yu. I. Pryamikova, V. V. Vodyanik, Ye. A. Nogovitsyn, S. I. Tkachev
Publicado em 2014-07-01

Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

Por D.  A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I.  P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov
Publicado em 2022-01-01

Successful experience in the use of ultrasound elastography in the differentiating of lymphomatous and metastatic superficial lymphadenopathy

Por E. V. Kovaleva, T. Yu. Danzanova, G. T. Sinyukova, E. A. Gudilina, P. I. Lepedatu, G. F. Allahverdieva, P. A. Zeynalova, V. B. Larionova, I. V. Kolyadina
Publicado em 2020-07-01

Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)

Por I V Kolyadina, I V Poddubnaya, Cornelis JH Van de Velde, P JK Kuppen, G A Frank, D V Komov, A I Karseladze, E Bastiaannet, N G Dekker-Ensink
Publicado em 2015-03-01

ASSOCIATION OF NKT- AND ACTIVATED CD25⁺ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS

Por A. I. Chertkova, E. G. Slavina, T. N. Zabotina, Z. G. Kadagidze, E. K. Shoua, O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Gan’shina, A. A. Meshcheryakov
Publicado em 2020-12-01

Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie)

Por I V Kolyadina, I V Poddubnaya, G A Frank, D V Komov, A I Karseladze, V D Ermilova, Ya V Vishnevskaya, N P Makarenko, K A Teterin, S M Banov, Zh M Guzieva
Publicado em 2012-03-01